Psychosis Clinical Trial
Official title:
A Case Series Study of Compassion Focused Therapy for Distressing Experiences
This study aims to develop and test the feasibility of a new therapy called Compassion
Focused Therapy (CFT) for psychosis. This therapy helps people with psychosis manage
distressing experiences by building internal feelings of safeness and affiliation, and by
providing contexts, practices and insights that facilitate the development of compassion to
self and others. The focus is on helping people feel safe in relation to their experiences
and their social worlds. CFT is a promising new approach that has been successfully provided
for people with a range of mental health difficulties. It is also firmly based in the most
up-to-date knowledge and science about how the mind works (both normally and under stress).
9 participants will be recruited from NHS psychological therapies services for people with
psychosis in South London and Maudsley (SLAM) NHS Foundation Trust. Following a short
baseline period they will receive up to 26 weekly sessions (about 6 months) of CFT with a
clinical psychologist, and will provide interview and questionnaire research data at five
different points during the study. At these assessment points, data will be gathered on
participants' experiences, mood, perceptions of their position in the social world, and heart
rate variability.
The initial therapy protocol has been developed by psychologists with expertise in CFT,
alongside people with lived experience of hearing voices and having distressing beliefs.
However, it will continue to be developed and evolve as the study progresses, and as more is
learnt (e.g. from the service-user participants) about applying the model in this population.
At the end of this study, the aim is to have all the information needed to run a randomised
controlled trial of this therapy.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04929938 -
Application of UP for Transdiagnostic Treatment of Emotional Disorders for UHR for Psychosis Patients
|
N/A | |
Recruiting |
NCT05863572 -
Strengthening Care in Collaboration With People With Lived Experience of Psychosis in Uganda
|
N/A | |
Completed |
NCT04277585 -
Improving Access to Early Psychosis Coordinated Specialty Care
|
N/A | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Terminated |
NCT04404712 -
FAAH Availability in Psychiatric Disorders: A PET Study
|
Early Phase 1 | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Not yet recruiting |
NCT05558332 -
Youth Nominated Support Team
|
N/A | |
Not yet recruiting |
NCT05358457 -
Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf)
|
N/A | |
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Completed |
NCT02895269 -
COllaborative Shared Care to IMprove Psychosis Outcome
|
N/A | |
Recruiting |
NCT02622048 -
Understanding and Helping Families: Parents With Psychosis
|
N/A | |
Completed |
NCT02653729 -
Cbt for Psychosis and Affect on Psychosis Symptoms
|
Phase 2 | |
Completed |
NCT02531243 -
Computer-Aided Learning for Managing Stress
|
N/A | |
Not yet recruiting |
NCT02244970 -
Mindfulness RCT for Early Psychosis
|
N/A | |
Enrolling by invitation |
NCT01364818 -
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
|
N/A | |
Withdrawn |
NCT00786318 -
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
|
Phase 4 | |
Recruiting |
NCT00722163 -
A Randomized Controlled Trial of Individual Therapy for First Episode Psychosis
|
Phase 0 | |
Completed |
NCT00272597 -
Risperidone LA Heathcare Resource Study
|
Phase 4 |